Growth Hormone Treatment for Non-GHD Disorders: Excitement Tempered by Biology
- PMID: 37450564
- PMCID: PMC10795916
- DOI: 10.1210/clinem/dgad417
Growth Hormone Treatment for Non-GHD Disorders: Excitement Tempered by Biology
Abstract
The success of growth hormone (GH) replacement in children with classical GH deficiency has led to excitement that other causes of short stature may benefit similarly. However, clinical experience has shown less consistent and generally less dramatic effects on adult height, perhaps not surprising in light of increased understanding of GH and growth plate biology. Nonetheless, clinical demand for GH treatment continues to grow. Upon the 20th anniversary of the US Food and Drug Administration's approval of GH treatment for idiopathic short stature, this review will consider the factors underlying the expansion of GH treatment, the biological mechanisms of GH action, the non-GH-deficient uses of GH as a height-promoting agent, biological constraints to GH action, and future directions.
Keywords: growth hormone; growth plate; indications; pediatric.
© The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
References
-
- Laron Z. The era of cadaveric pituitary extracted human growth hormone (1958–1985): biological and clinical aspects. Pediatr Endocrinol Rev. 2018;16(Suppl 1):11‐16. - PubMed
-
- Ranke MB, Wit JM. Growth hormone - past, present and future. Nat Rev Endocrinol. 2018;14(5):285‐300. - PubMed
-
- Wit JM, Kamp GA, Rikken B. Spontaneous growth and response to growth hormone treatment in children with growth hormone deficiency and idiopathic short stature. Pediatr Res. 1996;39(2):295‐302. - PubMed
-
- Parks JS. Gene sequence and production of recombinant MetGH/hGH. Pediatr Endocrinol Rev. 2018;16(Suppl 1):17‐27. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
